Kbc Group Nv Elanco Animal Health Inc Transaction History

Kbc Group Nv

$36.3 Billion
Q4 2024

A detailed history of Kbc Group Nv transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Kbc Group Nv holds 323,502 shares of ELAN stock, worth $3.73 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

323,502

Previous 88,662 264.87%

Holding current value

$3.73 Million

Previous $1.3 Million 200.92%

% of portfolio

0.01%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$11.63 - $14.67 $2.73 Million - $3.45 Million	234,840 Added 264.87%	323,502 $3.92 Million
Q3 2024 Nov 06, 2024	BUY	$11.85 - $15.47 $746 - $974	63 Added 0.07%	88,662 $1.3 Million
Q2 2024 Jul 17, 2024	BUY	$12.93 - $18.45 $20,390 - $29,095	1,577 Added 1.81%	88,599 $1.28 Million
Q1 2024 May 08, 2024	SELL	$14.37 - $16.46 $631,274 - $723,087	-43,930 Reduced 33.55%	87,022 $1.42 Million
Q4 2023 Feb 13, 2024	BUY	$8.6 - $14.94 $173,229 - $300,936	20,143 Added 18.18%	130,952 $1.95 Million
Q3 2023 Feb 15, 2024	BUY	$9.81 - $12.62 $93,891 - $120,786	9,571 Added 7.45%	138,008 $1.55 Million
Q2 2023 Feb 15, 2024	BUY	$8.08 - $10.37 $217,085 - $278,610	26,867 Added 26.45%	128,437 $1.29 Million
Q2 2023 Jul 28, 2023	SELL	$8.08 - $10.37 $122,403 - $157,095	-15,149 Reduced 12.03%	110,809 $1.12 Million
Q1 2023 Feb 14, 2024	SELL	$8.79 - $14.58 $199,365 - $330,688	-22,681 Reduced 14.23%	136,721 $1.29 Million
Q1 2023 May 04, 2023	BUY	$8.79 - $14.58 $221,314 - $367,095	25,178 Added 24.98%	125,958 $1.18 Million
Q4 2022 Feb 14, 2024	BUY	$11.49 - $13.65 $673,566 - $800,190	58,622 Added 58.17%	159,402 $1.95 Million
Q3 2022 Feb 15, 2024	SELL	$12.41 - $32.42 $364,630 - $952,564	-29,382 Reduced 22.44%	101,570 $1.26 Million
Q2 2022 Feb 14, 2024	BUY	$19.63 - $26.62 $234,558 - $318,082	11,949 Added 13.45%	100,780 $1.98 Million
Q2 2022 Jul 26, 2022	BUY	$19.63 - $26.62 $234,558 - $318,082	11,949 Added 13.45%	100,780 $1.98 Million
Q1 2022 Feb 14, 2024	SELL	$24.65 - $29.0 $455,458 - $535,833	-18,477 Reduced 17.22%	88,831 $2.32 Million
Q1 2022 May 06, 2022	SELL	$24.65 - $29.0 $455,458 - $535,833	-18,477 Reduced 17.22%	88,831 $2.32 Million
Q4 2021 Feb 14, 2024	SELL	$27.74 - $34.09 $655,884 - $806,023	-23,644 Reduced 18.06%	107,308 $3.05 Million
Q4 2021 Feb 03, 2022	SELL	$27.74 - $34.09 $848,455 - $1.04 Million	-30,586 Reduced 22.18%	107,308 $3.05 Million
Q3 2021 Nov 10, 2021	BUY	$29.2 - $36.72 $127,720 - $160,613	4,374 Added 3.28%	137,894 $4.4 Million
Q2 2021 Aug 11, 2021	BUY	$28.76 - $35.98 $675,313 - $844,846	23,481 Added 21.34%	133,520 $4.63 Million
Q1 2021 Apr 26, 2021	BUY	$27.85 - $34.49 $120,395 - $149,100	4,323 Added 4.09%	110,039 $3.24 Million
Q4 2020 Feb 10, 2021	BUY	$27.53 - $33.79 $145,633 - $178,749	5,290 Added 5.27%	105,716 $3.24 Million
Q3 2020 Oct 28, 2020	SELL	$21.1 - $29.13 $455,928 - $629,441	-21,608 Reduced 17.71%	100,426 $2.81 Million
Q2 2020 Aug 10, 2020	BUY	$18.94 - $24.93 $1.16 Million - $1.52 Million	61,166 Added 100.49%	122,034 $2.62 Million
Q1 2020 May 04, 2020	BUY	$16.68 - $32.25 $22,017 - $42,570	1,320 Added 2.22%	60,868 $1.36 Million
Q4 2019 Feb 11, 2020	SELL	$25.29 - $29.45 $4.81 Million - $5.6 Million	-190,173 Reduced 76.15%	59,548 $1.75 Million
Q3 2019 Nov 07, 2019	SELL	$25.62 - $34.96 $413,096 - $563,695	-16,124 Reduced 6.07%	249,721 $6.64 Million
Q2 2019 Jul 30, 2019	BUY	$31.11 - $34.79 $881,035 - $985,252	28,320 Added 11.92%	265,845 $0
Q1 2019 May 10, 2019	BUY	$29.0 - $32.83 $6.89 Million - $7.8 Million	237,525 New	237,525 $0

Others Institutions Holding ELAN

# of Institutions

445

Shares Held

474M

Call Options Held

4.62M

Put Options Held

753K

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.46B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account